Germany's Bayer will continue its expansion into the U.S. despite its announcement that its promising blood thinner candidate failed to demonstrate superiority over a competing medicine.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
